Literature DB >> 21911832

Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.

Renato D Lopes1, John D Horowitz, David A Garcia, Mark A Crowther, Elaine M Hylek.   

Abstract

Ms TS is a 66-year-old woman who receives warfarin for prevention of systemic embolization in the setting of hypertension, diabetes, and atrial fibrillation. She had a transient ischemic attack about 4 years ago when she was receiving aspirin. Her INR control was excellent; however, over the past few months it has become erratic, and her average dose required to maintain an INR of 2.0 to 3.0 appears to have decreased. She has had back pain over this same period and has been taking acetaminophen at doses at large as 650 mg four times daily, with her dose varying based on her symptoms. You recall a potential interaction and wonder if (1) her acetaminophen use is contributing to her loss of INR control, and (2) does this interaction place her at increased risk of warfarin-related complications?

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911832      PMCID: PMC5524527          DOI: 10.1182/blood-2011-08-335612

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  [Factors of therapeutic imbalance of antivitamins K and their haemorrhagic consequences in elderly].

Authors:  Guy Chatap; Karine Giraud; Virginie Delay; Catherine Cassereau; Sylvie Bastuji-Garin; Jean-Pierre Vincent; Henri-Pierre Cornu
Journal:  Therapie       Date:  2009-01-21       Impact factor: 2.070

2.  Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study.

Authors:  Terhi Launiainen; Antti Sajantila; Ilpo Rasanen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2009-09-25       Impact factor: 2.953

3.  Potentiation of oral anticoagulant therapy by acetaminophen.

Authors:  A M Antlitz; J A Mead; M A Tolentino
Journal:  Curr Ther Res Clin Exp       Date:  1968-10

Review 4.  Mechanisms of acetaminophen-induced liver necrosis.

Authors:  Jack A Hinson; Dean W Roberts; Laura P James
Journal:  Handb Exp Pharmacol       Date:  2010

5.  Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen.

Authors:  Laetitia Knockaert; Véronique Descatoire; Nathalie Vadrot; Bernard Fromenty; Marie-Anne Robin
Journal:  Toxicol In Vitro       Date:  2010-12-02       Impact factor: 3.500

6.  Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1.

Authors:  Joydeep Das; Jyotirmoy Ghosh; Prasenjit Manna; Parames C Sil
Journal:  Free Radic Res       Date:  2010-03

7.  Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

Authors:  Stuart J Connolly; Janice Pogue; John Eikelboom; Gregory Flaker; Patrick Commerford; Maria Grazia Franzosi; Jeffrey S Healey; Salim Yusuf
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

8.  Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity.

Authors:  P J Donnelly; R M Walker; W J Racz
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.

Authors:  Stephen Shalansky; Larry Lynd; Kathryn Richardson; Andrew Ingaszewski; Charles Kerr
Journal:  Pharmacotherapy       Date:  2007-09       Impact factor: 4.705

10.  The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.

Authors:  David Parra; Nick P Beckey; Gary R Stevens
Journal:  Pharmacotherapy       Date:  2007-05       Impact factor: 4.705

View more
  9 in total

1.  Warfarin and acetaminophen interaction in a 47-year-old woman.

Authors:  Derek Leong; Peter E Wu
Journal:  CMAJ       Date:  2020-05-11       Impact factor: 8.262

Review 2.  Cytochrome P450 interactions and clinical implication in rheumatology.

Authors:  Audrey Cayot; Davy Laroche; Anne Disson-Dautriche; Anaïs Arbault; Jean-Francis Maillefert; Paul Ornetti
Journal:  Clin Rheumatol       Date:  2014-06-14       Impact factor: 2.980

3.  Clinical and surgical outcomes of splenectomy for autoimmune hemolytic anemia.

Authors:  Sara Maskal; Raha Al Marzooqi; Aldo Fafaj; Samuel Zolin; Robert Naples; Advait Iyer; Clayton Petro; David Krpata; Ajita Prabhu; Michael Rosen; Steven Rosenblatt
Journal:  Surg Endosc       Date:  2022-02-22       Impact factor: 3.453

4.  Ultrasound-guided injection with hyaluronic acid in hip osteoarthritis: efficacy and safety in a real-life setting.

Authors:  Mihaela C Micu; Alexandru Micu; Sorana D Bolboacă
Journal:  Clin Rheumatol       Date:  2022-04-07       Impact factor: 3.650

Review 5.  Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records.

Authors:  Shobha Phansalkar; Amrita Desai; Anish Choksi; Eileen Yoshida; John Doole; Melissa Czochanski; Alisha D Tucker; Blackford Middleton; Douglas Bell; David W Bates
Journal:  BMC Med Inform Decis Mak       Date:  2013-06-13       Impact factor: 2.796

6.  Identification of environmental and genetic factors that influence warfarin time in therapeutic range.

Authors:  Mariana R Botton; Patrícia P Viola; Mariana R Meireles; Estela M Bruxel; Priccila Zuchinali; Eliane Bandinelli; Luis E Rohde; Tiago L L Leiria; Joyce Y Y Salamoni; Arthur P Garbin; Mara H Hutz
Journal:  Genet Mol Biol       Date:  2020-02-10       Impact factor: 1.771

7.  Factors influencing warfarin response in hospitalized patients.

Authors:  Mahmoud I Abdel-Aziz; Mostafa A Sayed Ali; Ayman K M Hassan; Tahani H Elfaham
Journal:  Saudi Pharm J       Date:  2015-02-27       Impact factor: 4.330

8.  Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study.

Authors:  Gebrehiwot Teklay; Nuredin Shiferaw; Befikadu Legesse; Mebratu Legesse Bekele
Journal:  Thromb J       Date:  2014-09-17

9.  A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction.

Authors:  Kaoru Yoshioka; Katsuya Ohmori; Soshi Iwasaki; Kazunobu Takahashi; Akemi Sato; Hiromasa Nakata; Atsushi Miyamoto; Michiaki Yamakage
Journal:  JA Clin Rep       Date:  2017-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.